You Don't Have to Be a Scientist to Have a Life Sciences CareerRead the rest of this entry »
Curious about a career in the life sciences industry, but you’re not a scientist? Don’t let that discourage you. Pharmaceutical companies have thousands of jobs in a variety of areas that don’t require biology or other science background.
The challenge for new entrants is that recruiters look for great talent with relevant experience. Whether you’re a recent or upcoming grad or a mid-career professional wanting to change industries, it’s up ...
Grocery Pharmacies Are Closing As Chains Take OverRead the rest of this entry »
As Big Pharma and the entire pharmaceutical sector generally transforms (see our previous articles), so too is the way consumers buy their drugs and fill prescriptions.
For the first time since grocers set-up pharmacies inside their markets, the number of these grocery pharmacies is
declining. The Wall Street Journal says hundreds of regional markets "are closing or selling pharmacy counters, which have been struggling as consumers make fewer trips ...
Clinical Research Hit By High TurnoverRead the rest of this entry »
Clinical research associates in the US are leaving jobs at the rate of 30% a year, says a new report from the consulting, tax and advisory firm, BDO.
Where turnover rates for these clinical monitoring professionals had been holding steady at 25%, the rate jumped between 2017 and 2018 by 4%. Outside the US, the global average is a modest 16%.
Turnover has plagued clinical / contract research organizations (CROs) ...
As Pharma Transforms, Drug Stocks Poised for ComebackRead the rest of this entry »
Big Pharma is poised for a financial comeback this year, even as both industry leaders and ambitious upstarts will navigate through choppy waters.
J.P. Morgan analyst Chris Schott wrote in mid-December that 2020 will be a recovery year for the stocks of major pharmaceutical companies. After a year in which the S&P 500 was up 25%, the S&P 500 Pharmaceuticals grew not even half that.
Schott basis his forecast on ...
6 Areas Where Biopharma Research Is Placing Its R&D EffortsRead the rest of this entry »
In what's described as the “new era of biopharmaceutical innovation," therapies unimagined a generation ago are being tested in trials across the globe. Many more are on the threshold while others, the subject of intense research, could turn out to be the next breakthrough.
In its 16th Annual Pipeline Report, Pharmaceutical Executive looks at six areas of biopharma R&D, .detailing the progress and status of the therapies, noting which ...
Pharma's Staffing Firms Are Playing a Bigger RoleRead the rest of this entry »
Pharmaceutical and life science companies have increasingly come to rely on functional service providers to staff specific development services including clinical trials.
FSPs, as they are commonly called, can ramp-up an operation more quickly and at a lower cost than can an in-house effort. The advantages go beyond speed and cost; flexibility is a special advantage FSPs provide. Projects and trials frequently have varying staffing needs, requiring more headcount at ...
Pharma Execs See Digitalization As Changing EverythingRead the rest of this entry »
A year ago, when pharma and life sciences CEOs were asked about the disruptions in their industry, by far they said technology was the only significant one.
What a difference a year makes. Now by a percentage rivaling last year's these executives say the opposite. 70% of the life sciences CEOs KPMG surveyed agreed that "Fast advancing technology is not the only significant disruption my business faces." In 2018, 85% ...
Biotech Startup Tackles the Challenge of Opioid AlternativesRead the rest of this entry »
What's lost in the struggle to deal with the national opioid crisis, is much discussion of alternatives.
Patients suffering acute pain -- surgical patients for example -- can be prescribed non-opioid analgesics, which are both effective and non-addicting. But, says Dr. Steven Fox, CEO of biotech Akelos, there are few choices to treat the kind of chronic pain associated with diabetes, shingles and cancer.
"Hundreds of millions of people worldwide ...
Will AI Replace Pharma Sales Reps?Read the rest of this entry »
Artificial intelligence is being deployed in all sorts of ways in all industries and pharma and the life sciences are no exception.
It's hardly surprising that AI is already an ally in simulations and data analysis, but does it have a role in pharmaceutical sales?
Yes, says David Logue, Senior Vice President of commercial strategy at the pharmaceutical software firm Veeva. Writing in PharmaExec.com, Logue says, "The next frontier ...
Pharma M&A Deal Volume Smallest In YearsRead the rest of this entry »
Vantage is out with a half-year review of developments and trends in pharma, medtech and biotech. The headline is that M&A activity has slowed despite two mega-deals worth a combined $137 billion.
Other deals pushed the total value of takeovers in the first half of the year to $173 billion. The report describes this as " an eye-watering sum that already beats the last three full years on total deal ...